World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
40603
World Ranking
5603
National Ranking
162

Overview

Jean Sibilia is affiliated with the University of Strasbourg in France, contributing extensively to the field of medicine with a particular focus on rheumatology, immunology, infectious diseases, pathology and forensic medicine, and genetics. Their work includes 344 publications in medicine, with specific attention to several subfields.

Their primary areas of research cover topics such as systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis and related diseases, inflammatory myopathies and dermatomyositis, as well as SARS-CoV-2 and COVID-19 research, including various clinical studies on COVID-19. These topics are supported by a body of work spanning dozens of publications in each domain.

Jean Sibilia has published numerous papers in notable scientific venues. Among the most frequent publication outlets are:

  • Revue du Rhumatisme
  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • La Revue de Médecine Interne
  • bioRxiv (Cold Spring Harbor Laboratory)

Their recent papers illustrate the scope of their research interests and contributions:

  • "Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France" (2020), published in Emerging infectious diseases
  • "Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis" (2020), published in Annals of Internal Medicine
  • "Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014" (2020), published in Autoimmunity Reviews
  • "Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases" (2021), published in The Lancet Rheumatology
  • "Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort" (2021), published in Science Translational Medicine

Jean Sibilia collaborates frequently with a select group of coauthors, reflecting interdisciplinary work and shared expertise. These frequent coauthors include:

  • Renaud Felten
  • Laurent Arnaud
  • Marc Scherlinger
  • Thierry Martin
  • Emmanuel Chatelus

Best Publications

  • Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

    Eric Hachulla;Virginie Gressin;Loïc Guillevin;Patrick Carpentier

  • Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome

    Jacques-Eric Gottenberg;Nicolas Cagnard;Carlo Lucchesi;Franck Letourneur

  • Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

    O Meyer;C Labarre;M Dougados;Ph Goupille

  • Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept - Twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial

    Joel J.M. Kremer;Maxime Dougados;Paul Emery;Patrick Durez

  • Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review

    Hélène Chifflot;Bruno Fautrel;Christelle Sordet;Emmanuel Chatelus

  • Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

    Xavier Mariette;Philippe Ravaud;Serge Steinfeld;Gabriel Baron

  • Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics and treatments in the QUEST-RA study

    Tuulikki Sokka;Sergio Toloza;Maurizio Cutolo;Hannu Kautiainen

  • Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases

    JE Gottenberg;L Guillevin;O Lambotte;B Combe

  • Treatment of Primary Sjögren Syndrome With Rituximab: A Randomized Trial

    Valérie Devauchelle-Pensec;Xavier Mariette;Sandrine Jousse-Joulin;Jean-Marie Berthelot

  • Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France

    Xavier Mariette;Dominique Cazals-Hatem;Josiane Warszawki;Frédéric Liote

  • MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

    Pierre-Antoine Juge;Joyce S Lee;Esther Ebstein;Hiroshi Furukawa

  • Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

    Benjamin Terrier;Zahir Amoura;Philippe Ravaud;Eric Hachulla

  • Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type

    Pierre Quartier;Pierre Taupin;Franck Bourdeaut;Irène Lemelle

  • Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France

    T Lequerré;P Quartier;D Rosellini;F Alaoui

  • Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.

    Michel De Bandt;Jean Sibilia;Xavier Le Loët;Sebastian Prouzeau

  • BONE MINERAL DENSITY IN MEN TREATED WITH SYNTHETIC GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PROSTATIC CARCINOMA

    J.F. Maillefert;J. Sibilia;F. Michel;C. Saussine

  • Lymphomas in Patients With Sjögren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses

    Bruno Royer;Dominique Cazals-Hatem;Jean Sibilia;Felix Agbalika

  • Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome

    Raphaèle Seror;Christelle Sordet;Loic Guillevin;Eric Hachulla

  • Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

    A Calin;B A C Dijkmans;P Emery;M Hakala

  • Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study.

    B Combe;M Dougados;P Goupille;A Cantagrel

Frequent Co-Authors

Xavier Mariette
Xavier Mariette University of Paris-Saclay
Eric Hachulla
Eric Hachulla University of Lille
Maxime Dougados
Maxime Dougados Hôpital Cochin
Xavier Puéchal
Xavier Puéchal Université Paris Cité
Bernard Combe
Bernard Combe University of Montpellier
Philippe Ravaud
Philippe Ravaud Université Paris Cité
Luc Mouthon
Luc Mouthon Université Paris Cité
Alain Saraux
Alain Saraux University of Western Brittany
Bruno Fautrel
Bruno Fautrel Université Paris Cité
Yannick Allanore
Yannick Allanore Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Many students interested in studying Medicine in the USA explore alternative degrees and flexible career pathways in healthcare. Online nursing programs continue to rise in popularity due to their accessibility and affordability. For those seeking entry-level credentials, cheap online nursing programs allow aspiring nurses to earn their qualifications with less financial strain.

Registered nurses (RNs) looking to advance their careers often consider programs that lead to a Bachelor of Science in Nursing. If you’re researching, you may be asking, what is the cheapest rn to bsn program online to upgrade their credentials efficiently.

For those aiming to become nurse practitioners, affordability remains crucial. Understanding your options is key—explore the cheapest np programs online that offer flexibility while preparing you for advanced clinical roles.

Finally, nurses who wish to reach the highest academic and professional levels can pursue an advanced degree through online phd programs nursing. These online options make it easier than ever to achieve top qualifications and expand your career while balancing work and family commitments.

Best Scientists Citing Jean Sibilia

Trending Scientists